HPV16整合源性外泌体c-Myc激活TREM-2+巨噬细胞免疫抑制功能促进宫颈上皮内瘤变进展的机制研究
批准号:
82101704
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
陈晓静
依托单位:
学科分类:
女性生殖系统炎症与感染
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
陈晓静
中文摘要
高危HPV整合诱导的免疫逃逸在CIN进展中发挥重要作用,其调控机制尚不明确。在前期证实HPV16整合与巨噬细胞表型及功能改变密切关联的基础上,本项目预实验显示HPV16高频整合位点基因产物c-Myc以外泌体转载的形式促进TREM-2+巨噬细胞极化并激活其对效应T细胞的免疫抑制功能;生物信息学预测TREM-2结合DAP12参与T细胞功能调控的下游通路是RAS-MAPK,正性调控Arg1表达。由此我们提出科学假说:HPV16整合源性外泌体c-Myc作用于巨噬细胞,通过TREM-2/DAP12/RAS-MAPK/Arg1信号轴重塑宫颈局部免疫抑制微环境,促进CIN进展。本项目拟利用高通量病毒整合检测、外泌体示踪、CRISPR/Cas9-sgRNA全基因组文库筛选、HPV16转基因CIN小鼠模型等关键技术,探讨高危HPV整合相关CIN进展的免疫逃逸机制,为临床早期预测和阻断CIN进展提供新靶点。
英文摘要
High-risk HPV integration-induced immune escape plays an important role in the progression of cervical intraepithelial neoplasia (CIN). However, the underlying mechanism is still elusive. On the basis of previous studies confirming that HPV16 integration was closely related to phenotypic and functional changes of macrophages, our preliminary experiment further demonstrated that HPV16 high- frequency integration site gene product c-Myc was transferred into macrophages in the form of exosome, promoting the polarization of TREM-2+ macrophages and activating its immunosuppressive function against effector T cells. Bioinformatics predicts that the downstream pathway of TREM-2 combined with DAP12 involved in the regulation of T cell function is RAS-MAPK, which positively regulates the expression of Arg1. Therefore, we propose that HPV16 integration-derived exosomal c-Myc acts on macrophages to reshape the local cervical immunosuppressive microenvironment through TREM-2/DAP12/RAS-MAPK/Arg1 signal axis and promotes the progression of CIN. This study intends to use several key technologies, such as high-throughput viral integration detection, exosome tracking, genome-wide library screening of CRISPR/Cas9-sgRNA, HPV16 transgenic CIN mouse model, etc., to explore the immune escape mechanism of high-risk HPV integration-related CIN progression, which will provide scientific evidence for exploring early prediction and effective therapeutic targets of inhibiting the progression in CIN.
高危HPV整合诱导免疫逃逸进而持续感染是宫颈上皮内瘤变(CIN)进展的前提事件,而女性生殖道中宫颈局部微环境的免疫状态是决定CIN转归的关键因素。宫颈免疫微环境中肿瘤细胞生物学行为的改变、细胞外成分的释放以及巨噬细胞的功能活化等与CIN进展密切关联,其调控机制仍不甚明了。本项目围绕上述关键因素,通过体内、外功能研究及临床样本验证,系统地探讨高危HPV16整合感染宫颈免疫抑制微环境中的致病因素及其调控机制。我们的研究结果表明:1)HPV16高频整合位点基因c-Myc以外泌体转载的形式作用于巨噬细胞,通过转录调控TREM-2的表达,促进巨噬细胞功能活化;2)TREM-2+巨噬细胞吞噬作用减弱,且通过分泌Arg1细胞因子诱导CD8+T细胞功能耗竭,重塑宫颈局部免疫抑制微环境;3)HPV16整合通过调控c-Myc/miR-142-5p/HOXA5/SLC7A11信号轴抑制宫颈肿瘤细胞铁死亡,促进CIN进展;4)缺氧诱导的ZEB1高表达在宫颈癌细胞源性外泌体中富集,促进SIRPα+TAMs极化,通过启动CD47-SIRPα“不吃我”信号使肿瘤细胞逃避免疫监视并促进肿瘤进展。以上研究结果阐明HPV16整合感染宫颈微环境中肿瘤细胞~外泌体~巨噬细胞~免疫逃逸这一级联过程中的信号分子、互动关系及调控机制,为开发宫颈癌进展的早期标志物和有效治疗靶点提供科学依据。在本项目资助下共发表 SCI论文4篇(其中3篇IF>5分),会议投稿交流3篇,申报国家发明专利1项,培养博士后1名,获得广东省医学会优秀论文一等奖,得到同行的广泛关注和认可。
缺氧肿瘤相关巨噬细胞IL-10/STAT3/SLC7A11轴通过调控胱氨酸转运系统稳定性抑制宫颈癌细胞铁死亡的机制研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:陈晓静
-
依托单位:
国内基金
海外基金